trending Market Intelligence /marketintelligence/en/news-insights/trending/x-mmq9mchm1ykj5fhos6cg2 content esgSubNav
In This List

Endra Life Sciences prices common stock offering

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Endra Life Sciences prices common stock offering

Ann Arbor, Mich.-based Endra Life Sciences Inc. priced its underwritten public offering of 1,285,000 common shares at $2.10 apiece.

The healthcare equipment company granted National Securities Corp., the sole book-running manager in the transaction, an overallotment option to buy up to an additional 192,750 common shares.

Endra expects to raise gross proceeds of about $2.7 million in the offering. If the underwriter's option is fully exercised, gross proceeds may amount to about $3.1 million.

The transaction is expected to close by Oct. 15, subject to customary closing conditions.

Through the offering, the developer of medical imaging technology may be able to regain compliance with Nasdaq's listing rule on the minimum stockholders' equity value of $2.5 million.